Estrogens can cause liver cholestatic disease. As downregulation of hepatocyte canalicular aquaporin-8 (AQP8) water channels has been involved in estrogen-induced bile secretory failure, we tested whether the archetypal water channel AQP1 improves 17α-ethinylestradiol (EE)-induced cholestasis. EE administration to rats reduced bile flow by 50%. A recombinant adenoviral (Ad) vector encoding human AQP1 (hAQP1), AdhAQP1, or a control vector was administered by retrograde bile ductal infusion. Hepatocyte canalicular hAQP1 expression was confirmed by liver immunostaining and immunoblotting in purified membrane fractions. Accordingly, canalicular osmotic water permeability was markedly increased. Bile flow, either basal or bile salt-stimulated was significantly augmented by over 50%. The choleretic efficiency of endogenous bile salts (that is, volume of bile per μmol of excreted bile salt) was significantly increased by 45% without changes in the biliary bile salt composition. Our data suggest that the adenoviral transfer of hAQP1 gene to the livers of EE-induced cholestatic rats improves bile flow by enhancing the AQP-mediated bile salt-induced canalicular water secretion. This novel finding might have potential therapeutic implications for cholestatic diseases.
INTRODUCTION
Cholestasis is characterized by impairment of bile formation and it is caused by many liver diseases. Chronic cholestasis can progress toward biliary cirrhosis and liver failure requiring liver transplantation. Estrogens are well known to cause liver cholestatic disease, whose clinical manifestations are cholestasis associated with pregnancy or postmenopausal replacement therapy and oral contraceptive-induced cholestasis. 1 Experimental cholestasis induced by estrogen administration to rodents, mainly 17α-ethinylestradiol (EE), is an established experimental model used to investigate the mechanisms of estrogen-induced bile secretory dysfunction. 2 Aquaporins (AQPs) are a family of protein channels that facilitates the osmotically driven water movement across cell membranes.
3 AQP8, localized in the canalicular plasma membrane domain of hepatocytes, has been involved in water transport during bile formation. 4, 5 Previously, we suggested that a reduced canalicular membrane water permeability resulting from downregulation of hepatocyte AQP8 expression contributes to the molecular pathogenesis of EE-induced cholestasis. 6 Adenovirus vectors are widely used for in vivo gene therapy. The gene transfer of the archetypal human water channel AQP1 via the adenoviral vector AdhAQP1 has been successfully used to restore normal salivary flow to irradiated hypofunctional salivary gland of experimental animals 7, 8 and humans. 9 The purpose of this study was to test whether the administration of the AdhAQP1 vector can promote AQP1-mediated canalicular water secretion and improve bile secretory failure in rats with estrogen-induced cholestasis.
RESULTS AND DISCUSSION
The major finding in this study relates to the functional significance of canalicularly expressed hAQP1 water channels in the hepatocyte bile secretion in cholestasis. We provide experimental evidence that the adenoviral gene delivery of hAQP1 to livers of EE-induced cholestatic rats, (i) induced hAQP1 canalicular expression and consequently, increased the canalicular osmotic membrane water permeability; (ii) increased bile flow under basal and taurocholate-stimulated conditions; and (iii) enhanced the choleretic efficiency of endogenous bile salts. An important role for AQP-mediated canalicular water permeability in improving hepatocyte bile secretory dysfunction in estrogen-induced cholestasis is suggested.
Hepatocyte expression of hAQP1 in AdhAQP1-transduced rats Figure 1a shows immunohistochemistry and confocal immunofluorescence microscopy for AQP1. In agreement with the reported endogenous hepatic AQP1 expression, 10 AQP1 staining was intense in peribiliary vascular endothelia and weak in bile duct epithelial cells (cholangiocytes) of rat livers transduced with control vector, but absent in hepatocytes. Similar results were observed in livers from EE-treated rats transduced with control vector (not shown). AdhAQP1 administration in non-cholestatic and EE-treated rats induced the expression of hAQP1 in hepatocytes (Figure 1a ). Cholangiocytes did not show any clear increased staining for AQP1 (Figure 1a ). In hepatocytes, hAQP1 was primarily located in plasma membranes without accumulation in intracellular organelles. Importantly, hAQP1 expression could be observed in the bile secretory pole of hepatocytes, that is, the canalicular plasma membrane (Figure 1a) . The hepatocyte plasma membrane expression of hAQP1 did not differ between normal and EE-treated rats (Figure 1b) , suggesting that EE-induced cholestasis did not impair vector infection and hAQP1 expression. Immunoblotting studies confirmed the expression of hAQP1 1 mainly in hepatocyte canalicular plasma membranes of EE-treated rats (Figure 1c) .
To determine whether the expressed hAQP1 protein was functional, canalicular osmotic water permeability was measured by stopped-flow spectrophotometry. Canalicular membranes from cholestatic rats transduced with AdhAQP1 vector showed fivefold average increase in water permeability over cholestatic rats transduced with control vector (Figure 2 ). This indicates that a functional hAQP1 protein was expressed in hepatocyte canaliculi of cholestatic rats.
Under our experimental conditions, AdhAQP1 administration induced hAQP1 expression in roughly 20% of hepatocytes based on immunostainings (Figure 1a ) and the percentage of canalicular vesicles with high water permeability (see Figure 2 and corresponding legend). This percentage of hepatocytes transduced via a retrograde adenovector infusion is in fairly good agreement with previous reports. 11, 12 It is important to mention that periportal hepatocytes (the hepatocytes closest to the portal venules in the liver acinus) are predominantly transduced after adenoviral retrograde bile ductal infusion 12 and that these cells are the primary hepatocytes for bile formation. 13 Thus retrograde biliary infusion induced suitable hAQP1 hepatocyte expression, in addition to cause no significant adverse effects as shown in Table 1 and reported previously. 12 In accordance, AdhAQP1 transfer via retrograde ductal infusion to salivary glands shows no significant hepatic toxicity.
14 Intrabiliary infusion allows the delivery of adenovirus to hepatocytes with minimal leak outside the liver because of the anatomical constraints of the biliary tract 15 and besides, excess adenovirus is delivered immediately into the duodenum and excreted in the stool. Thus repetitive transgene hepatic expression could be achieved by intrabiliary infusion without immunosuppression. 16 Bile flow in AdhAQP1-transduced cholestatic rats Bile formation by hepatocytes is an osmotic secretory process resulting from the canalicular secretion of water in response to osmotic gradients created by the active transport of solutes, primarily bile salts and other organic anions. Thus bile flow is ultimately dependent on the canalicular expression of transporters such as the bile salt export pump Bsep/Abcb11 and the multidrug-resistant protein Mrp2/Abcc2, and the water permeability of the canalicular plasma membrane domain mainly determined by AQPs. 4, 5, 17 Impairment of these basic processes of canalicular fluid secretion is believed to be the primary event in the development of cholestasis induced by estrogen. 4, 18, 19 Thus we studied whether the AQP1-induced increase in canalicular water permeability could affect the flow of bile in cholestatic rats. As shown in Figure 3a , bile flow was increased by 51% in cholestatic rats transduced with AdhAQP1 vector. As bile salts are key solutes in bile formation by hepatocytes, we also studied the bile flow under stimulation. To stimulate hepatocyte (canalicular) bile flow, we made use of the physiological bile salt taurocholate, which is efficiently taken up by hepatocytes and excreted into bile. 20 Bile flow stimulated by taurocholate was 70% higher in cholestatic rats transduced with AdhAQP1 than with control vector (Figure 3b ). Taurocholate-induced bile flow (that is, taurocholate-stimulated bile flow over basal values) was increased threefold between these groups of rats ( Figure 3b) .
Thus, hepatic hAQP1expression in EE cholestatic rats significantly increased basal and bile salt-stimulated bile flow.
Thus, the AQP1-induced increase in canalicular water permeability of EE cholestatic rats significantly augmented basal and bile salt-stimulated bile flow.
Choleretic efficiency of bile salts in AdhAQP1-transduced cholestatic rats As bile formation by hepatocytes is an osmotic process primarily driven by bile salts, the increased canalicular water permeability observed in our studies (Figure 2 ) could have led to an increased water secretion in response to the output of bile salts. Thus, we studied whether the improved bile flow may be associated with an enhanced osmotic efficiency of excreted bile salts. The choleretic efficiency of endogenous bile salts (that is, volume of bile per μmol of excreted bile salt) was estimated from the slope of the relationship between bile flow and bile salt output during depletion of the bile salt pool by interruption of the enterohepatic circulation 21 ( Figure 4a , left panel). Cholestatic rats transduced with AdhAQP1 showed a choleretic efficiency of total endogenous bile salts 45% higher than cholestatic rats transduced with control vector (Figure 4a , right panel). As individual endogenous bile salts may have different choleretic efficiencies, we assessed biliary bile salt composition by high-performance liquid chromatography. These studies indicated that the individual biliary bile salt composition was not significantly different between the above-mentioned groups of cholestatic rats (Figure 4b ). Thus the enhanced choleretic efficiency of bile salts seems to be the result of the increased canalicular water permeability. This is supported by the estimated choleretic efficiency of taurocholate (μl of bile per μmol of excreted bile salt), estimated from the data in Figure 3 : 5.1 ± 0.4 (non-cholestatic controls); 2.5 ± 1.0* (EE+Adc) and 5.9 ± 0.9 (EE+AdhAQP1), *P o0.05.
Our data suggest that the increased canalicular water permeability induced by hAQP1 transgene expression allowed a more efficient coupling between bile salts and water transport during bile secretion in cholestatic hepatocytes. As a result, there was an increased amount of bile-water osmotically driven by excreted bile salts. Bile consists mostly of water, and normal bile-water flow is necessary to keep small bile ducts open and to prevent the precipitation of biliary constituents so that flow is not 27 . L, low P f , calculated from the slow rate constant of a double-exponential fit. H, high P f , calculated from the fast rate constant of a double-exponential fit. W, weighted P f , calculated using the low and high P f and their percentages of contribution to the total, that is, W = (L × 80+H × 20)/100. Data are mean values ± s.e.m. from three independent vesicle preparations. *P o0.05 as compared with canalicular vesicles from cholestatic liver treated with control vector. 
987 ± 171 913 ± 13 811 ± 222 781 ± 132 637 ± 157 Body weight (g) 335 ± 9 368 ± 14 347 ± 9 333 ± 7 336 ± 7 Liver weight (g) 12.5 ± 0. Aquaporin-1 gene transfer improved cholestasis J Marrone et al obstructed. 22 Besides, biliary aqueous phase functions as the liquid vehicle for vesicles and micelles in bile to transport them to the intestine and thus permit their excretion. The function of biliary water is mostly self-protection 22 and therefore, a normal canalicular water transport would reduce the risk of bile secretory dysfunction.
We previously reported an AQP-mediated decrease of hepatocyte canalicular water permeability in other experimental model of cholestasis, that is, sepsis-associated cholestasis. 23 Thus, an AdhAQP1-mediated improvement of bile secretion in sepsisassociated cholestasis may be anticipated. In fact, AdhAQP1 administration may be beneficial to treat or prevent different liver diseases in which hepatocellular (non-obstructive) cholestasis occurs. In addition, AdhAQP1-induced biliary water content may help to reduce bile viscosity in certain pathological states. 24 Ursodeoxycholic acid is currently the only established drug for the treatment of cholestatic liver diseases. 25 As hAQP1 gene transfer improved bile flow (Figure 3 ) and the retrograde biliary infusion is an approach that would be clinically feasible by means of endoscopic retrograde cholangiography, AdhAQP1 delivery might be effective for treatment of bile secretory failure.
In conclusion, our data suggest that the adenoviral transfer of hAQP1 gene to the livers of EE cholestatic rats improves bile flow by enhancing the AQP-mediated bile salt-induced canalicular water secretion. This novel finding might have potential therapeutic implications for cholestatic diseases.
MATERIALS AND METHODS

Animals and treatments
Adult male Wistar rats were maintained on a standard laboratory diet and water ad libitum and housed in a temperature-and humidity-controlled environment under a constant 12-h lightdark cycle. All animals received humane care, according to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health). Protocols were approved by the local animal welfare committee. EE (Sigma-Aldrich, St Louis, MO, USA) (5 mg per kg body weight) was administered subcutaneously for five consecutive days. Non-cholestatic control rats received only the EE vehicle (propylene glycol). Under these conditions, 6 EE induced cholestasis as indicated by 50% bile flow reduction and cholestatic parameters (Table 1) .
Adenoviral vectors
AdhAQP1 is a replication-deficient serotype 5 recombinant adenovirus encoding hAQP1 and including a cytomegalovirus promoter and simian virus 40 polyadenylylation site. AdhAQP1 was kindly donated by Dr Bruce Baum (NIDCR, NIH, Bethesda, MD, USA); details of the construction procedures have been described elsewhere. 7 The adenoviral vector used as control (Adc) is also a replication-deficient serotype 5 recombinant adenovirus that encodes β-galactosidase. Both vectors employed (Adc and AdhAQP1) are first-generation constructs lacking the E1 region. In vivo delivery of recombinant adenovirus to the biliary tract After the third EE injection, rats were anesthetized with a dose of ketamine (100 mg per kg body weight)/xylazine (15 mg per kg body weight, intraperitoneal). A 2-cm transversal laparotomy was made just below the xiphoid appendix to expose the duodenum. The duodenal antimesenteric wall was punctured with a 25G needle and a PE-10 polyethylene catheter (Intramedic, Clay Adams, Parsippany, NJ, USA) was introduced first into the lumen of the duodenum and then through the papilla of Vater 1 cm into the bile duct. A virus dose of 3 × 10 10 pfu per liver suspended in 300 μl of sterile saline was retrogradely infused into the biliary tract during a period of 3 min. In additional control experiments, animals received only 300 μl of sterile saline. The catheter was maintained in place for 15 min to prevent backflow. After the procedure was completed the catheter was gently removed, the duodenal puncture and abdominal wall were sutured and the animal was allowed to recover. The experiments were performed 72 h after adenoviral infusion (that is, on day 6 after starting EE treatment). We performed, in advance, initial experiments to determine the optimal administration dose of adenovirus.
Bile secretion studies After treatments, rats were anesthetized as mentioned above and maintained under this condition during bile collection. For this purpose, a middle abdominal incision was made and the common bile duct was cannulated with a PE-10 polyethylene tubing. Bile was collected for three 10-min periods. Thereafter, we injected bile salt taurocholate (Sigma, St Louis, MO, USA) (8 μmol per 100 g body weight, intravenous) to stimulate hepatocyte (canalicular) bile flow, and bile was collected for an additional 10-min period. Bile flow was determined by gravimetry, assuming a density of the bile of 1.0 g ml − 1
. 6 At the end of bile collection, blood samples were taken by cardiac puncture, animals were euthanized by exsanguination and the livers harvested for evaluation.
Liver serum parameters Activity of enzymes aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) were determined in serum using commercial kits (Wiener Lab, Rosario, Argentina), according to the manufacturer's instructions.
Choleretic efficiency of endogenous bile salts Rats were anesthetized and the bile duct was cannulated with a PE-10 polyethylene tubing. Bile was collected for 6 h in 1-h intervals. Bile flow was determined as mentioned above and total bile salt concentration was assessed using the 3α-hydroxysteroid dehydrogenase procedure. 26 The choleretic efficiency of endogenous bile salts (that is, volume of bile per μmol of excreted bile salt) was estimated from the slope of the relationship between bile flow and bile salt output. 21 Biliary bile salt composition In the first and sixth 1-h periods of bile collected for assessment of the choleretic efficiency of endogenous bile salts (see above), Liver homogenates were subjected to low-speed centrifugation to obtain postnuclear supernatants. Fractions enriched in plasma membranes were prepared from liver homogenates by centrifugation at 200 000 g for 60 min on a discontinuous 1.3 M sucrose gradient as previously described. 28 The plasma membrane band was removed, diluted to 0.3 M, and centrifuged at 200 000 g for 60 min to yield the plasma membrane fraction, which was further purified by centrifugation at 100 000 g for 90 min on a continuous (9-60%) sucrose gradient. 28 Purified plasma membranes were layered onto a discontinuous sucrose gradient composed of 31, 34 and 38% sucrose. After centrifugation at 270 000 g for 3 h, the band at the top of the 31% layer (canalicular plasma membrane) and the band at the top of the 38% layer (basolateral plasma membrane) were collected, diluted with washing buffer and spun at 200 000 g for 1 h. 29 Membrane proteins were determined according to the method of Lowry et al. 30 by using bovine serum albumin as standard.
Canalicular water permeability
The time course of canalicular vesicular volume was followed from changes in scattered light intensity at 450 nm by using a SX.18MVR stopped-flow spectrometer (Applied Photophysics, Surrey, UK) as previously described by our laboratory. 6 The osmotic water permeability coefficient (P f ) was calculated as described 6,29 using the equation:
where K exp is the fitted exponential rate constant, V o is the initial mean vesicle volume, A v is the mean vesicle surface, V w is the molar volume of water and ΔC is the osmotic gradient. V o and A v were calculated by using a mean canalicular vesicle diameter of 160 ± 9 nm, assessed by morphometric analysis of electron micrographs. 6 Immunoblotting Western blotting of membrane fractions was performed as previously described by our laboratory 6,28 using rabbit affinitypurified AQP1 antibodies (1 μg ml − 1 ; Alpha Diagnostics International, San Antonio, TX, USA) and mouse β-actin antibodies (1 μg ml − 1 ; Sigma) and horseradish peroxidase-conjugated corresponding secondary antibodies (DakoCytomation, Glostrup, Denmark). Protein bands were detected by enhanced chemiluminescence detection system (ECL, Thermo Scientific, Rockford, IL, USA). Autoradiographs were obtained by exposing the membranes to Kodak XAR films (Eastman Kodak, Rochester, NY, USA). Densitometric analysis of the developed bands was performed using ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA). 31 Immunohistochemistry Livers were perfused with phosphate-buffered saline to eliminate the blood and then they were fixed, processed and embedded in paraffin as described. 6, 28 AQP1 was localized with affinity-purified antibodies (10 μg ml − 1 ; Alpha Diagnostics International) and horseradish peroxidase-conjugated secondary antibodies (DakoCytomation) on serial 5-μm sections. Controls were performed by omitting the primary antibodies. Images were captured with an E 600 photomicroscope equipped with a DMX 1200 digital camera (Nikon, Kawasaki, Japan). The slides were developed by incubating with 0.06% 3,3-diaminobenzidine and 0.01% H 2 O 2 for 5 min and counterstained using hematoxylin.
Confocal immunofluorescence microscopy and image analysis Fixed liver sections were permeabilized and blocked with 0.2% Triton X-100/bovine serum albumin 3% for 10 min and incubated overnight at 4°C with rabbit affinity-purified AQP1 antibodies (10 μg ml − 1 ). After washing, samples were incubated with Alexa 488-conjugated goat anti-rabbit secondary antibody (Molecular Probes, Eugene, OR, USA) for 1 h. Samples were washed, incubated with 4′,6-diamidino-2-phenylindole (Molecular Probes) (50 μM) for 10 min and mounted with ProLong (Molecular Probes). Fluorescence localization was detected by confocal microscopy (Nikon C1PlusSiR with inverted microscope Nikon TE2000, Melville, NY, USA). Images were collected with the same confocal settings in each set of experiments. With these settings no autofluorescence was detected. Controls omitting primary or secondary antibodies revealed no labeling. For the sake of clarity, contrast and brightness adjustments were equally applied to the entire images via Adobe Photoshop software (San Jose, CA, USA).
Transduction efficiency of AdhAQP1 in hepatocytes from cholestatic rats was estimated from the confocal immunofluorescence images using the NIH ImageJ program. 31 Several images with around 400 cells each were used. Images corresponding to the Adc vector were used as fluorescence background for setting the scale for image analysis. Positively stained hepatocytes represent roughly 20% of total cells counted.
Statistical analysis
Data are expressed as means ± s.e.m. Significance was determined by Student's t-test or the one-way analysis of variance, Tukey's test. P o 0.05 was considered statistically significant.
